AbbVie Inc. (ABBV) vs MCDONALDS CORP(MCD)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | ABBV | MCD |
|---|---|---|
| Sector | Health Care | Consumer Discretionary |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $61.16B | $26.89B |
| Revenue growth (YoY) | ▲ 8.6% | ▲ 3.7% |
| Net income | $4.23B | $8.56B |
| Gross margin | — | — |
| Diluted EPS | $2.36 | $11.95 |
| Insider net (6 mo) | −11.6K sh · 3 sells · 0 buys | −3.6K sh · 8 sells · 0 buys |
| Institutional owners | 46 | 52 |
| Institutional value held | $222.87B | $98.12B |
| Next earnings (est.) | Around Oct 30, 2026 | Nov 4, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About AbbVie Inc. (ABBV)
AbbVie Inc., incorporated in Delaware in 2012, is a global, diversified research-based biopharmaceutical company that became an independent, publicly-traded entity on January 1, 2013, following its spin-off from Abbott Laboratories.
About MCDONALDS CORP (MCD)
McDonald's Corporation is a global quick-service restaurant company operating and franchising McDonald's restaurants across more than 100 countries, with 40,275 restaurants at year-end 2022, approximately 95% of which were franchised.
Source: SEC EDGAR.